Shivinder Mohan Singh

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search

Shivinder Mohan Singh
Shivinder Singh in WEF ,2009.jpg
Shivinder Mohan Singh at the World Economic Forum, 2009
ResidenceNew Delhi, India
Alma materDuke University (MBA)

Shivinder Mohan Singh is an Indian business man and erstwhile billionaire with Fortis Healthcare (now sold), Religare and Ranbaxy Laboratories (now sold). Singh was the non-executive vice chairman of Fortis Healthcare, an Indian company. He is the son of Dr. Pravinder Singh, and grandson of Bhai Mohan Singh, the founder of Ranbaxy Laboratories,[1] since merged with Sun Pharmaceuticals Ltd ( was earlier a unit of the Japanese drug maker, Daiichi Sankyo. He and his brother Malvinder Mohan Singh[2] inherited their family's 33.5% stake in Ranbaxy after the death of their father in 1999. In April 2015, they were the thirty-fifth-richest Indians with a net worth of $2.5 billion.[3]

Singh attended The Doon School, and then graduated with a BA (hons.) in mathematics from St. Stephen's College, Delhi and holds an MBA with specialisation in health sector management from the Fuqua School of Business of Duke University in the United States.[4]

Singh lives in New Delhi, along with his wife Aditi and their four sons. On 24 September, in the annual AGM of Fortis Hospitals, Shivinder announced his resignation and handing over control of the hospital chain to his brother. He would be shifting to Radha Soami Satsang Beas and devoting full time to this community.


  1. ^ "40 Years Ago... And now: Ranbaxy grew with liberal regimes, moving out of family control". Business Standard. Retrieved 17 December 2014.
  2. ^ "Fortis - In the pick of healthcare". Business Today. Retrieved 17 December 2014.
  3. ^ "Malvinder & Shivinder Singh on Forbes Lists". Forbes. Retrieved 17 December 2014.
  4. ^ "Shivinder Mohan Singh". Bloomberg. Retrieved 17 December 2014.